← Back

Early anti-TNF vs azathioprine after ileocolic resection

Does adjuvant anti-TNF therapy reduce postoperative endoscopic recurrence more effectively than azathioprine when started within two weeks of ileocolic resection

ComparisonNot yet clinician-reviewed

What is known

  • Savarino three-arm RCT: endoscopic recurrence over 2 years of follow-up 6.3% adalimumab vs 64.7% azathioprine vs 83.3% mesalazine. 1–3
  • A POCER sub-analysis showed 6-month endoscopic recurrence higher with thiopurine (45%) than adalimumab (21%). 2
  • Two network meta-analyses ranked anti-TNF monotherapy as most effective, significantly above thiopurine for preventing endoscopic and clinical recurrence. 2
  • ECCO recommends drug prophylaxis best started within 2 weeks of surgery, though optimal timing remains undetermined. 1

What is unknown / caveats

  • A Middle Eastern cohort found no significant association between either biologics or azathioprine and prevention of endoscopic recurrence in moderate-high-risk patients
  • The 2-week start window is a guideline recommendation, not the variable tested in the head-to-head trials. Timing was not isolated
  • Superiority data come largely from a small RCT (n=51) and network meta-analyses, not a large timing-stratified trial
  • Optimal timing and duration of anti-TNF prophylaxis after surgery remain undetermined by controlled data.

References

  1. Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn's disease: what does the future hold?. Drugs. 2013;73(16):1749-59. PMID: 24132799.
  1. Yerushalmy-Feler A, Assa A. Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn's Disease. Paediatr Drugs. 2019;21(6):451-460. PMID: 31628665.
  1. Thienpont C, Van Assche G. Endoscopic and medical management of fibrostenotic Crohn's disease. Dig Dis. 2014;32 Suppl 1:35-8. PMID: 25531351.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.


Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.

Reviewer notes

answered 2026-08-04 · corpus build 89548d50 · faithfulness 0.875